Global Market for Biobank Equipments Growth, Trends and Forecasts (2017 - 2022)

The biobank equipment market was valued at USD 144.9 million in 2014 and is expected to become a USD 194.93 million market by 2019. During this period, the market is expected to show a CAGR of 6.23%.

Global Market for Biobank Equipment- Market Dynamics

The report lists several driving and restraining factors for the global biobank equipment market. Some of them are listed below.


The vision of personalized medicine

Poor productivity rate of the pharmaceutical industry with respect to the new drug approvals

Need to contain the ever-increasing healthcare costs

Research and development processes from early discovery through clinical trials

Advances in regenerative medicine, drug discovery and biobanking techniques


Privacy, confidentiality and surveillance issues

Access policies and procedures

Regulation-based issues with biobanking procedures

Fear of privatization

Lack of proper governance

Storage problems

Cost competitive procedures

Currently, regulatory systems are not favorable and this does not facilitate cutting edge research across borders in the most efficient and economical manner.

The biobank equipment market was segmented on the basis of equipment used, and geography. The major equipment and types used in the biobank sector are Refrigerators, Freezers, Ice machines, Cryogenic storage systems, Alarm monitoring systems and LN2 Supply Tanks.

From the geographical point of view, the US has the largest market share, followed by the European market. Recent developments in this market have contributed to the growth of the emerging markets. They are expected to show stiff competition to the developed economies.

Some of the key players in the market are:

Atlanta Biologicals

Biolife Solutions

Biopreservation Media Manufacturers

Bioniche Pharma USA LLC

Cell & Tissue Systems LLC

Essential Pharmaceuticals

What the Report Offers

Market analysis for the biobank equipment market, with region-specific assessments and competition analysis on the global and regional scale.

Market definition along with the identification of key drivers and restraints.

Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale.

Extensively researched competitive landscape section with profiles of major companies along with their market share.

Identification and analysis of the macro and micro factors that affect the biobank equipment market on both global and regional scale.

A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.

A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market.

Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped.


1.1 Report Description

1.2 Research Methodology

1.3 Stakeholders


2.1 Key Findings

2.2 Market Overview


3.1 Market Definition

3.1.1 Introduction

3.2 Market Drivers

3.2.1 Investment by Government & Non-Governmental Organizations

3.2.2 Rise in Chronic Diseases

3.2.3 Advances in Regenerative Medicine

3.2.4 Advances in Drug Discovery & Development

3.3 Market Restraints

3.3.1 Regulatory Issues

3.3.2 Storage Problems

3.3.3 High-Cost techniques


4.1 Refrigerators

4.2 Ice Machines

4.3 Freezers

4.4 Cryogenic Storage Systems

4.5 Alarm Monitoring Systems

4.6 LN2 Supply Tanks


5.1 North America

5.1.1 USA

5.1.2 Canada

5.1.3 Mexico

5.2 Europe

5.2.1 UK

5.2.2 Germany

5.2.3 France

5.2.4 Spain

5.3 APAC

5.3.1 China

5.3.2 Japan

5.3.3 India

5.3.4 South Korea

5.4 Rest of World

5.4.1 Brazil


6.1 Introduction

6.2 Mergers & Acquisitions

6.3 Expansions

6.4 New Product Launch

6.5 Collaborations


7.1 Biopreservation Media Manufacturers

7.2 Atlanta Biologicals

7.3 Biolife Solutions

7.4 Bioniche Pharma USA LLC

7.5 Cell & Tissue Systems LLC

7.6 Essential Pharmaceuticals

7.7 Lifeline Scientific Inc.

7.8 Genzyme Corporation

7.9 Preservation Solution

7.10Sigma Aldrich Corporation

7.11 Teva Pharmaceutical Industries Ltd

8. Appendix

Content are not available

Choose License Type